간·담낭·소화기

SGLT2 inhibitors in biopsy-proven MASH patients with diabetes: Systematic review and meta-analysis (abstract interpretation)

A single-arm meta-analysis of diabetic patients with biopsy-proven MASH found SGLT2 inhibi…

EASL‑EASD‑EASO Guidance: resmetirom and semaglutide Recommended Use in MASH

This summary compiles the 2026 joint guidance, describing when to consider resmetirom or s…

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Risk of Atrial Fibrillation Recurrence After Catheter Ablation: Systematic Review and Met

A systematic review and random-effects meta-analysis showed MASLD and higher liver fibrosi…

What Hepatitis B Carriers Should Know: What to Monitor, When to Start Antivirals, and Why Immunosuppression (Including Dialysis and Transplant) Can Reactivate the Virus

About 250 million people live with chronic hepatitis B; in Taiwan adult carriage is still…

Fatty Liver Is More Than "Fat in the Liver": The MASLD Rename, How to Calculate FIB-4, Who Needs Fibrosis Testing, and How Much Weight Loss Works

About 1 in 3 adults worldwide has fatty liver; in Taiwan and Japan prevalence is around 30…